What are the elvitegravir (Vitekta) dosing guidelines for antiretroviral therapy of HIV infection?

Updated: Apr 18, 2019
  • Author: R Chris Rathbun, PharmD, BCPS (AQ-ID), AAHIVP; Chief Editor: John Bartlett, MD  more...
  • Print


Elvitegravir (Vitekta) (Note: Discontinued in the U.S. and Europe in 2016):

  • Dosage forms: 85-mg, 150-mg tablet
  • Adult dose: 85 mg PO once daily plus atazanavir or lopinavir plus ritonavir or 150 mg PO once daily plus darunavir or fosamprenavir or tipranavir plus ritonavir
  • Comments: Take with food
  • Adverse events: Immune reconstitution syndrome

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!